Two leading innovators in the type 1 diabetes (T1D) space have announced a collaborative partnership aimed at enabling those with T1D to select favorite devices, knowing they all work together, even if made by different companies.
The nonprofit company Tidepool announce that it is partnering with leading pump manufacturer Medtronic to create an interoperable automated insulin pump system.
Breakthrough T1D is an early supporter of Tidepool and a strong advocate for Open Protocol, which calls for T1D technologies to all work together, even if made by different manufactures.
Through the partnership, Medtronic will develop a future Bluetooth-enabled MiniMed™ pump that would be compatible with Tidepool Loop, an open-source automated insulin delivery app for iPhone and Apple Watch currently in development.
“In an era of empowered health consumers, this collaboration opens up new opportunities for people with diabetes to choose the technology that’s right for them,” said Howard Look, Tidepool Founder and CEO.
The two companies announced their partnership at the 79th Scientific Sessions of the American Diabetes Association (ADA) being held in San Francisco.
Tidepool Loop is an automated insulin delivery app for iPhone that connects to an insulin pump and CGM using Bluetooth LE. It runs an algorithm every five minutes to adjust your basal rate for the next 30 minutes, helping you reduce or avoid high and low blood glucose.
As part of the agreement, Medtronic will contribute financial support to Tidepool for the integration development effort and develop a software development kit to enable iPhone to pump communication.
Read more here.
